Evidence map›Paper›PMID 29968850›Full record

ArticleModern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc2019

Correction: TERT promoter mutation in adult granulosa cell tumor of the ovary.

Jessica A Pilsworth, Dawn R Cochrane, Zhouchunyang Xia, Geraldine Aubert, Anniina E M Färkkilä, Hugo M Horlings, Satoshi Yanagida, Winnie Yang, Jamie L P Lim, Yi Kan Wang and 16 more

Open access · greenAbstract readPublished Erratum
PubMed Publisher
In one paragraph

Article in Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 91% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

26 authors at 9 institutions in 7 countries.

Jessica A PilsworthDepartment of Medical Genetics, University of British Columbia, Vancouver, BC, Canada.
Dawn R CochraneDepartment of Molecular Oncology, British Columbia Cancer Agency, Vancouver, BC, Canada.
Zhouchunyang XiaDepartment of Molecular Oncology, British Columbia Cancer Agency, Vancouver, BC, Canada.
Geraldine AubertTerry Fox Laboratory, British Columbia Cancer Agency, Vancouver, BC, Canada.
Anniina E M FärkkiläChildren's Hospital and Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Hugo M HorlingsDepartment of Molecular Oncology, British Columbia Cancer Agency, Vancouver, BC, Canada.
Satoshi YanagidaDepartment of Obstetrics and Gynecology, The Jikei University School of Medicine, Tokyo, Japan.
Winnie YangDepartment of Molecular Oncology, British Columbia Cancer Agency, Vancouver, BC, Canada.
Jamie L P LimDepartment of Molecular Oncology, British Columbia Cancer Agency, Vancouver, BC, Canada.
Yi Kan WangDepartment of Molecular Oncology, British Columbia Cancer Agency, Vancouver, BC, Canada.
Ali BashashatiDepartment of Molecular Oncology, British Columbia Cancer Agency, Vancouver, BC, Canada.
Jacqueline KeulDepartment of Women's Health, Tübingen University Hospital, Tübingen, Germany.
Adele WongDepartment of Pathology, Massachusetts General Hospital, Boston, MA, USA.
Kevin NorrisDivision of Cancer and Genetics, School of Medicine, Cardiff University, Cardiff, UK.
Sara Y BruckerDepartment of Women's Health, Tübingen University Hospital, Tübingen, Germany.
Florin-Andrei TaranDepartment of Women's Health, Tübingen University Hospital, Tübingen, Germany.
Bernhard KrämerDepartment of Women's Health, Tübingen University Hospital, Tübingen, Germany.
Annette StaeblerTübingen University Hospital, Institute of Pathology, Tübingen, Germany.
Hannah van MeursDepartment of Gynecology, Center for Gynecologic Oncology Amsterdam, Academic Medical Center, 1100 DD, Amsterdam, The Netherlands.
Esther OlivaDepartment of Pathology, Massachusetts General Hospital, Boston, MA, USA.
Sohrab P ShahDepartment of Molecular Oncology, British Columbia Cancer Agency, Vancouver, BC, Canada.ORCID http://orcid.org/0000-0001-6402-523X
Stefan KommossDepartment of Women's Health, Tübingen University Hospital, Tübingen, Germany.
Friedrich KommossInstitute of Pathology, Campus Bodensee, Friedrichshafen, Germany.
C Blake GilksDepartment of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada.
Duncan M BairdDivision of Cancer and Genetics, School of Medicine, Cardiff University, Cardiff, UK.
David G HuntsmanDepartment of Molecular Oncology, British Columbia Cancer Agency, Vancouver, BC, Canada. dhuntsma@bccancer.bc.ca.
BC Cancer Agency · CAUniversity Children's Hospital Tübingen · DECardiff University · GBMassachusetts General Hospital · USAmsterdam UMC Location University of Amsterdam · NLJikei University School of Medicine · JPMedizin Campus Bodensee · DEUniversity of British Columbia · CAUniversity of Helsinki · FI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The original version of this Article omitted the author Hannah van Meurs from the Department of Gynecology, Center for Gynecologic Oncology Amsterdam, Academic Medical Center, 1100 DD Amsterdam, The Netherlands. This has been corrected in both the PDF and HTML versions of the article.

Identifiers

PMID29968850
OpenAlexW2811253064

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.